Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
$6.32M Sell
81,214
-1,077
-1% -$80.1K 0.38% 67
2021
Q1
$6.05M Buy
82,291
+53,421
+185% +$3.94M 0.4% 67
2020
Q4
$2.25M Buy
28,870
+2,191
+8% +$168K 0.16% 137
2020
Q3
$2.11M Sell
26,679
-2,757
-9% -$216K 0.17% 127
2020
Q2
$2.17M Sell
29,436
-1,066
-3% -$80.3K 0.19% 115
2020
Q1
$2.24M Buy
30,502
+5,528
+22% +$434K 0.26% 94
2019
Q4
$2.17M Buy
24,974
+592
+2% +$48.6K 0.19% 157
2019
Q3
$1.96M Sell
24,382
-9,946
-29% -$797K 0.19% 148
2019
Q2
$2.75M Sell
34,328
-14,535
-30% -$1.11M 0.28% 114
2019
Q1
$3.88M Sell
48,863
-245
-0.5% -$18.3K 0.42% 74
2018
Q4
$3.58M Sell
49,108
-40,655
-45% -$2.87M 0.48% 59
2018
Q3
$6.08M Sell
89,763
-8,641
-9% -$551K 0.62% 40
2018
Q2
$5.7M Sell
98,404
-48,639
-33% -$2.74M 0.61% 45
2018
Q1
$7.64M Buy
147,043
+42,584
+41% +$2.3M 0.84% 25
2017
Q4
$5.61M Sell
104,459
-4,685
-4% -$260K 0.62% 45
2017
Q3
$6.67M Hold
109,144
0.86% 23
2017
Q2
$6.67M Buy
109,144
+22,576
+26% +$1.37M 0.86% 23
2017
Q1
$5.25M Sell
86,568
-13,906
-14% -$844K 0.77% 30
2016
Q4
$5.64M Buy
100,474
+11,584
+13% +$678K 0.87% 21
2016
Q3
$5.29M Sell
88,890
-3,444
-4% -$201K 0.88% 16
2016
Q2
$5.08M Sell
92,334
-1,948
-2% -$104K 0.85% 22
2016
Q1
$4.76M Buy
94,282
+3,799
+4% +$186K 0.86% 24
2015
Q4
$4.56M Buy
90,483
+5,564
+7% +$281K 0.99% 25
2015
Q3
$4M Buy
84,919
+36,769
+76% +$1.95M 1% 23
2015
Q2
$2.62M Buy
48,150
+3,987
+9% +$224K 0.69% 36
2015
Q1
$2.42M Buy
44,163
+33,943
+332% +$1.92M 0.65% 38
2014
Q4
$554K Sell
10,220
-314
-3% -$17.5K 0.15% 160
2014
Q3
$596K Buy
10,534
+2,760
+36% +$155K 0.18% 145
2014
Q2
$429K Sell
7,774
-13,083
-63% -$714K 0.14% 166
2014
Q1
$1.13M Sell
20,857
-5,163
-20% -$267K 0.41% 67
2013
Q4
$1.24M Sell
26,020
-1,256
-5% -$57.4K 0.5% 54
2013
Q3
$1.24M Buy
27,276
+1,077
+4% +$49.2K 0.56% 50
2013
Q2
$1.16M Buy
+26,199
New +$1.17M 0.58% 40

Other funds holding MRK

USCA RIA's MRK Position: Q2 2021 in Review

USCA RIA reduced its Merck (MRK) stake by 1.3% in Q2 2021, selling an estimated $80.1K and leaving 81,214 shares worth $6.32M. The position accounts for 0.38% of the portfolio, ranked #67.

USCA RIA first reported a position in MRK in Q2 2013 and has held it in 33 quarters since. The position peaked at $7.64M in Q1 2018. 2,673 funds tracked by Wall St. Rank hold MRK as of Q2 2021.

  • USCA RIA held 81,214 shares of Merck worth $6.32M as of Q2 2021.
  • USCA RIA sold 1,077 Merck shares in Q2 2021, an estimated $80.1K.
  • Merck made up 0.38% of USCA RIA's portfolio in Q2 2021, its #67 holding.
  • USCA RIA first reported a position in Merck in Q2 2013 and has held it in 33 quarters since.
  • USCA RIA's Merck position peaked at $7.64M in Q1 2018.
  • 2,673 funds tracked by Wall St. Rank held Merck as of Q2 2021.

Based on USCA RIA's 13F filing for Q2 2021, filed 28 Jul 2021.